Jost S - Search Results

1

Harnessing innate and adaptive immunity for viral vaccine design.

Jost S, Altfeld M, Chang JJ. Jost S, et al. Expert Rev Vaccines. 2012 Jul;11(7):775-7. doi: 10.1586/erv.12.48. Expert Rev Vaccines. 2012. PMID: 22913253 Free PMC article.

2

MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.

Nolting A, Dugast AS, Rihn S, Luteijn R, Carrington MF, Kane K, Jost S, Toth I, Nagami E, Faetkenheuer G, Hartmann P, Altfeld M, Alter G. Nolting A, et al. Among authors: jost s. Virology. 2010 Oct 10;406(1):12-20. doi: 10.1016/j.virol.2010.05.014. Epub 2010 Jul 29. Virology. 2010. PMID: 20667578 Free PMC article.

3

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

Alter G, Jost S, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, Altfeld M, Lauer GM. Alter G, et al. Among authors: jost s. J Hepatol. 2011 Aug;55(2):278-88. doi: 10.1016/j.jhep.2010.11.030. Epub 2010 Dec 17. J Hepatol. 2011. PMID: 21168454 Free PMC article.

4

Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.

Jost S, Reardon J, Peterson E, Poole D, Bosch R, Alter G, Altfeld M. Jost S, et al. Immunology. 2011 Apr;132(4):516-26. doi: 10.1111/j.1365-2567.2010.03394.x. Epub 2011 Jan 7. Immunology. 2011. PMID: 21214542 Free PMC article.

5

Changes in cytokine levels and NK cell activation associated with influenza.

Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, Parry BA, Bryant NN, Binder WD, Altfeld M. Jost S, et al. PLoS One. 2011;6(9):e25060. doi: 10.1371/journal.pone.0025060. Epub 2011 Sep 23. PLoS One. 2011. PMID: 21966414 Free PMC article.

6

Evasion from NK cell-mediated immune responses by HIV-1.

Jost S, Altfeld M. Jost S, et al. Microbes Infect. 2012 Sep;14(11):904-15. doi: 10.1016/j.micinf.2012.05.001. Epub 2012 May 21. Microbes Infect. 2012. PMID: 22626930 Free PMC article. Review.

7

Control of human viral infections by natural killer cells.

Jost S, Altfeld M. Jost S, et al. Annu Rev Immunol. 2013;31:163-94. doi: 10.1146/annurev-immunol-032712-100001. Epub 2013 Jan 3. Annu Rev Immunol. 2013. PMID: 23298212 Review.

8

Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.

Jost S, Moreno-Nieves UY, Garcia-Beltran WF, Rands K, Reardon J, Toth I, Piechocka-Trocha A, Altfeld M, Addo MM. Jost S, et al. Retrovirology. 2013 Jul 18;10:74. doi: 10.1186/1742-4690-10-74. Retrovirology. 2013. PMID: 23866914 Free PMC article.

9

CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.

Jost S, Tomezsko PJ, Rands K, Toth I, Lichterfeld M, Gandhi RT, Altfeld M. Jost S, et al. J Virol. 2014 Aug;88(15):8349-54. doi: 10.1128/JVI.00924-14. Epub 2014 May 14. J Virol. 2014. PMID: 24829350 Free PMC article.

10

Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM.

Palmer CD, Tomassilli J, Sirignano M, Romero-Tejeda M, Arnold KB, Che D, Lauffenburger DA, Jost S, Allen T, Mayer KH, Altfeld M. Palmer CD, et al. Among authors: jost s. AIDS. 2014 Sep 10;28(14):2162-6. doi: 10.1097/QAD.0000000000000386. AIDS. 2014. PMID: 25003719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters